Æó°æ ÈÄ ¿©¼ºÀÇ Àü´Ü°è ¹× 1±â °íÇ÷¾Ð¿¡ ´ëÇÑ Ä§ Ä¡·á: ´Ù±â°ü ¹«ÀÛÀ§ ´ëÁ¶ ¿¹ºñ¿¬±¸
Acupuncture for Prehypertension and Stage 1 Hypertension in Postmenopausal Women: Protocol for a Randomized Controlled Pilot Trial

Korean Journal of Acupuncture 2014³â 31±Ç 1È£ p.5 ~ p.13

±èÁ¤Àº:Kim Jung-Eun ÃÖÁøºÀ:Choi Jin-Bong/±èÇüÁØ:Kim Hyung-Jun/°­°æ¿ø:Kang Kyung-Won/·ù¿¬:Liu Yan/Á¤ÈñÁ¤:Jung Hee-Jung/À̹ÎÈñ:Lee Min-Hee/½Å¹Ì¼÷:Shin Mi-Suk/±èÀçÈ«:Kim Jae-Hong/ÃÖ¼±¹Ì:Choi Sun-Mi

Abstract

¸ñÀû : º» ¿¬±¸´Â Àü´Ü°è ¹× 1±â °íÇ÷¾Ð¿¡ ÇØ´çÇÏ´Â Æó°æ ÈÄ ¿©¼ºÀ» ´ë»óÀ¸·Î ħ Ä¡·áÀÇ À¯È¿¼º°ú ¾ÈÀü¼ºÀ» Æò°¡ÇÏ°í ÀûÁ¤ Ä¡·á Ƚ¼ö¸¦ Ž»öÇÒ ¸ñÀûÀ¸·Î ½Ç½ÃÇÏ´Â ¿¬±¸ÀÌ´Ù.

¹æ¹ý : ³× ±º, ¹«ÀÛÀ§ ¹èÁ¤, °ø°³ ¿¹ºñ¿¬±¸°¡ µÎ Àӻ󿬱¸¼¾ÅÍ¿¡¼­ ÁøÇàµÉ °ÍÀÌ´Ù. ÃÑ 60¸íÀÇ ´ë»óÀÚ°¡ µÎ Ä¡·á±º°ú µÎ ´ëÁ¶±º¿¡ ¹èÁ¤µÇ°Ô µÈ´Ù. Ä¡·á±ºÀÇ ´ë»óÀÚ´Â Åë»óÀû °ü¸®¿Í ÇÔ²² 8°³ Ç÷À§(¾çÃø dzÁö, °îÁö, Á·»ï¸®, »ïÀ½±³)¿¡ Ä¡·á±º A´Â 4ÁÖ°£ 10ȸ, Ä¡·á±º B´Â 8ÁÖ°£ 20ȸ ħ Ä¡·á¸¦ ¹ÞÀ» °ÍÀÌ´Ù. ´ëÁ¶±ºÀÇ ´ë»óÀڴ ħ Ä¡·á¸¦ ¹ÞÁö ¾Ê°í ´ëÁ¶±º C´Â 16ÁÖ°£, ´ëÁ¶±º D´Â 20ÁÖ°£ Åë»óÀû °ü¸®¸¦ ÇÏ°Ô µÈ´Ù. °¢ ´ë»óÀÚÀÇ »ýÈ°½À°üÀº ±³Á¤µÉ °ÍÀ̸ç Ç÷¾Ð¿¡ ¿µÇâÀ» ÁÙ ¼ö ÀÖ´Â ¾à¹°Àº ±ÝÁöµÉ °ÍÀÌ´Ù. Ä¡·á±º A¿Í ´ëÁ¶±º C´Â ¹«ÀÛÀ§ ¹èÁ¤ 4, 8, 12, 16ÁÖ ÈÄ¿¡, Ä¡·á±º B¿Í ´ëÁ¶±º D´Â ¹«ÀÛÀ§ ¹èÁ¤ 4, 8, 12, 16, 20ÁÖ ÈÄ¿¡ Æò°¡¸¦ ¹ÞÀ» °ÍÀÌ´Ù. ÁÖ¿ä°á°úº¯¼ö´Â ¹«ÀÛÀ§ ¹èÁ¤ 4ÁÖ ÈÄ À̿ϱâ Ç÷¾Ð º¯È­·®ÀÌ´Ù. º¸Á¶°á°úº¯¼ö´Â (1) ¹«ÀÛÀ§ ¹èÁ¤ 8, 16, 20ÁÖ ÈÄ À̿ϱâ Ç÷¾Ð º¯È­·®, (2) ¼öÃà±â Ç÷¾Ð º¯È­·®, (3) Ç÷¾Ð Á¶Àý·ü, (4) ÁöÁú´ë»çÁöÇ¥, (5) °í°¨µµ C-¹ÝÀÀ´Ü¹éÀÌ´Ù.

°á·Ð : º» ¿¬±¸ÀÇ °á°ú´Â Ç÷¾Ð Á¶Àý¿¡ ´ëÇÑ Ä§ÀÇ À¯È¿¼º ¹× ¾ÈÀü¼º¿¡ °üÇÑ ±Ù°Å ±¸Ãà¿¡ µµ¿òÀÌ µÉ °ÍÀÌ´Ù.
Objectives : This study aims to evaluate the effectiveness and safety of acupuncture and explore the appropriate number of treatment for postmenopausal women diagnosed with prehypertension and stage 1 hypertension.

Methods : A 4-arm randomized open label pilot trial will be performed at 2 centers. Sixty participants will be divided into 2 treatment groups and 2 control groups. Treatment groups will receive acupuncture at 8 points(bilateral GB20, LI11, ST36, SP6) for 4 weeks(treatment group A, 10 total sessions) or 8 weeks(treatment group B, 20 total sessions), while maintaining usual care. Control groups will not receive acupuncture but will be under usual care for 16 weeks(control group C) or 20 weeks(control group D). Each patient¡¯s living habits will be corrected and drugs that may affect blood pressure(BP) will be prohibited. Treatment group A and control group C will be evaluated at 4, 8, 12, and 16 weeks after randomization, while treatment group B and control group D will be evaluated at 4, 8, 12, 16, and 20 weeks after randomization. The major outcome variable is the magnitude of change in diastolic BP levels at 4 weeks after randomization; auxiliary outcome variables are (1) diastolic BP change at 8, 16, and 20 weeks, (2) systolic BP change, (3) BP control rate, (4) lipid profiles, and (5) high-sensitivity C-reactive protein. Patient safety will be assessed at every visit.

Results and Conclusions : The study findings may help develop evidence for the effectiveness and safety of acupuncture for BP control.

Å°¿öµå

acupuncture, prehypertension, hypertension, randomized controlled trial
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
The study findings may help develop evidence for the effectiveness and safety of acupuncture for BP control.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå